Whalen Wealth Management Inc. Purchases 1,304 Shares of Intuitive Surgical, Inc. $ISRG

Whalen Wealth Management Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 1,304 shares of the medical equipment provider’s stock, valued at approximately $530,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Motiv8 Investments LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $34,000. Main Street Group LTD bought a new position in Intuitive Surgical during the 1st quarter worth approximately $30,000. North Point Portfolio Managers Corp OH acquired a new position in Intuitive Surgical during the third quarter valued at approximately $27,000. Vermillion Wealth Management Inc. grew its holdings in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares during the period. Finally, Evergreen Advisors LLC bought a new stake in Intuitive Surgical in the first quarter valued at approximately $35,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays initiated coverage with an Overweight rating and later upgraded ISRG to Strong Buy. The firm’s bullish stance provides a positive catalyst and suggests confidence in Intuitive Surgical’s market position despite a softer medical-device environment. Barclays initiates coverage of Intuitive Surgical at Overweight Intuitive Surgical upgraded at Barclays
• Positive Sentiment: Wall Street analysts remain optimistic. Coverage highlights expectations for year-over-year revenue and earnings growth, while Citi has also issued a Buy rating. Such recommendations may encourage buying interest in the shares. Wall Street analysts look optimistic on Intuitive Surgical Intuitive Surgical gets a Buy from Citi
• Positive Sentiment: The da Vinci Single-Port platform is gaining momentum. Rising procedure volumes, utilization, placements, expanding indications and international adoption could create another significant recurring-revenue growth engine for Intuitive Surgical. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Investors are focused on the upcoming October 20 earnings report. Results and management’s outlook will be important in determining whether the recent analyst optimism and expected growth are justified. Barclays’ bullish initiation amid rising rivalry
• Negative Sentiment: Competition and valuation remain risks. Commentary points to growing rivalry, particularly from Johnson & Johnson, while ISRG’s premium valuation could limit upside or increase sensitivity to an earnings miss. Intuitive Surgical and JNJ give Jim Cramer more than valuation to consider

Intuitive Surgical Price Performance

ISRG stock traded down $0.50 during trading hours on Thursday, reaching $414.02. 878,915 shares of the stock were exchanged, compared to its average volume of 2,414,874. The firm’s 50-day moving average is $383.70 and its 200-day moving average is $411.61. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The company has a market cap of $146.27 billion, a price-to-earnings ratio of 47.50, a PEG ratio of 3.05 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.Intuitive Surgical’s quarterly revenue was up 18.4% on a year-over-year basis. During the same period last year, the company earned $1.81 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Insider Activity

In other news, EVP Mark Brosius sold 77 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the sale, the executive vice president owned 881 shares of the company’s stock, valued at $330,877.17. The trade was a 8.04% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary S. Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the transaction, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. The trade was a 0.80% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 12,370 shares of company stock worth $4,891,989. 0.60% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. Mizuho set a $500.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Barclays upgraded Intuitive Surgical to a “strong-buy” rating in a report on Wednesday. Piper Sandler reissued an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a report on Friday, July 17th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $502.53.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.